Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses

By Kato H.   Bukawa H.   Hagiwara E.   Xin K.-Q.K.-Q.   Hamajima K.   Kawamoto S.   Sugiyama M.   Sugiyama M.   Noda E.   Nishizaki M.   Okuda K.  

Vaccine, Vol. 18, Iss. 13, 2000-01 ,pp. : 1151-1160

Elsevier

Access to resources Recommend Favorite

Characterization of a multi-lipopeptides mixture used as an HIV-1 vaccine candidate

By Klinguer C.   David D.   Kouach M.   Wieruszeski J.-M.   Tartar A.   Marzin D.   Levy J.-P.   Gras-Masse H.  

Vaccine, Vol. 18, Iss. 3, 1999-09 ,pp. : 259-267

Elsevier

Access to resources Recommend Favorite

Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in mice

By Liang X.   Fu T.-M.   Xie H.   Emini E.A.   Shiver J.W.  

Vaccine, Vol. 20, Iss. 27, 2002-09 ,pp. : 3413-3421

Elsevier

Access to resources Recommend Favorite

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

By Kistner O.   Barrett P.N.   Mundt W.   Reiter M.   Schober-Bendixen S.   Dorner F.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 960-968

Elsevier

Access to resources Recommend Favorite

Development, expression, and murine testing of a multistage Plasmodium falciparum malaria vaccine candidate

By Shi Y.P.   Das P.   Holloway B.   Udhayakumar V.   Tongren J.E.   Candal F.   Biswas S.   Ahmad R.   Hasnain S.E.   Lal A.A.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2902-2914

Elsevier

Access to resources Recommend Favorite